We describe two modifications of a double-isotope assay for measuring the concentrations of oestrogen receptors and progesterone receptors in tumour cytosols and extracts of frozen tumour sections and endometrial sections. The concentrations of these receptors are derived from single-point/isoelectric focussing assays after incubation of cytosols or section supernatants either with ([ H]pregn-4-ene-3,20-dione). The concentrations of the oestrogen and progesterone receptors found in cytosols (r > 0.93) and extracts from sections (r > 0.8) by dual label assays are highly correlated with those found by single label assays. The method described represents an approach to the determination of oestrogen and progesterone receptors biochemically in an amount of tissue which is comparable to that needed for immunocytochemical procedures.
Introduction
In human breast cancer, oestrogen and progesterone receptors represent an established determinant for their prognosis and serve äs a guideline for their treatment. In view of the significantly longer survival times of patients with receptor-positive endometrial cancer (1) , oestrogen receptor and progesterone receptor determinations provide useful prognostic data.
The most frequently appüed method for the quantitation öf the receptor content is the measurement of specific high affinity binding sites after incubation of tissue cytosols with radiolabeled receptor ligands (2, 3) . During the last few years, antibodies directed against the oestrogen receptor (4) and progesterone receptor molecule (5) have been used either in immunocytochemical assays (6 -11) or in enzyme immunoassays (12) (13) (14) . Conventional cytosolic ligand binding assays and enzyme immunoassays deliver quantitative results (fmol/ mg), but at the expense of a relatively large amount of tissue. On the other band, the immunocytochemical assay of frozen sections provides only semiquantitative scores of labelled cells, whereas enzyme immunoassays are expensive, especially if the number of specimen to be tested does not fit with the number of assays in the kit. In addition these kits have an upper limit for a given receptor concentration of an undiluted cytosol.
As an alternative, for a single receptor species (15 -17) , we, like others, have recently developed an assay for both the determination of oestrogen receptor and progesterone receptor (18) in frozen sections of unfixed tumour tissue. To further minimize the amount of tissue needed, and to determine both receptor species quantitatively and simultaneously from the same set of frozen sections, we describe an assay in which sections are incubated in the presence of an iodinated gestagenic and tritiated oestrogenic ligand and vice versa, according to assays described for cytosols (19) (20) (21) (22) .
Materials and Methods
Endometrial tissue and endoraetrial carcinomas were obtained after hysterectomy, and human breast cancer specimens were obtained immediately after surgical removal. Samples suitable for either homogenisation or cryostat microtomy were trimmed of fat or necrotic tissue.
Chemicals and buffers
Radiolabelied ligands, [2, 4, 6 All test tubes were incubated for 2 h at 4 °C. After incubation, 100 μΐ supernatant were transferred to an isoelectric focussing gel, in order to separate bound, unbound and unspecifically bound hormone.
Preparation and incubation of sections
Duplicate sets of cryostat sections (30 μπι) to give a final section area of about l cm 2 were collected on small glass coverslips and gently crushed into glass tubes containing 360 μΐ of the buffer. To mimic a cytosol preparation with cryostat sections the sections were extracted for 2 h in the hypotonic medium, centrifuged at 800 g, the supernatants incubated and the receptors separated and determined s described for cytosols. Protein was determined in 50 μΐ supernatant (23) .
Isoelectric focussing
Specifically bound, unbound and unspecifically bound fractions of hormone were separated by isoelectric focussing of 2 mm thick polyacrylamide gels using a horizontal electrophoresis chamber. Each gel had a final volume of 60 ml and contained 48.5 g/l acrylamide (Merck, Darmstadt), 1.5 g/l bisacrylamide (Merck, Darmstadt), 115 ml/l glycerol (87%), 15 ml/l ampholines pH =3-10 and 10 ml/l ampholines pH =5-8 (both LKB, Sweden). Polymerizalion was started by the addition of 180 ul of ammonium peroxodisulphate (100 g/l). The following Solutions were used in the electrode compartments: cathode, l mol/1 sodium hydroxide; an de, 25 mmol/1 aspartic acid and glutamic acid.
Samples (100 μΐ) were pipetted into prefonned slots near the cathodic electrode strip. Isoelectric fooussing was perfonned on a cooling plate at 0°C using a multiphor Instrument (LKB, Sweden). The gel was prefocussed until reading 100 V (30-45 min) using a constant current of 10 mA. After sample application, the gel was focussed until reading 200V (30-60 min), then a constant current was set at 15 mA with a limiting power setting of 18 W to avoid heating of the gel. The focussing gel was run until reading 1250-1300 V (approx. another 30 min). At the end of the run the gel was fractioned manually. First the gel was cut into sample-containing Strips. These were cut into 3 mm pieces beginning at the alkaline side of the gel and ending at the acidic side. These 3 min pieces were then transferred into microvials containing 4 ml Xylofluor liquid scintillation Cocktail (Baker, Holland). Gel slices were extracted for 45 min at 50 °C and radioactivity was determined in a Rackbeta liquid scintillation counter (LKB, Sweden).
Counting and evaluation
In contrast to Pollow et al. (22), we did not perfonn an external standardisation, but used instead the auto-window-setting mode of the beta-counter for [ ] double label counting (Rackbeta; LKB, Sweden). In this mode the counter defines two energy Windows of the beta-spectrum, in which a sample will be counted. In addition, an internal programme for automatic quench compensation ensures the adaptation of the energy Windows according to the quenched amount of counts of an external Standard superimposed on the radioactive sample.
Calculation of results
In this counting mode the counter defines the energy Windows (channel l and 2) according to the respective beta-spectrum for each sample individually, and according to the counts in a channel after their adaptation by the internal quench compensation. In this way the ratio of iodine counts in the low energy part of the spectrum (channel 1) and in the high energy part of the spectrum (channel 2) is constant and in the r nge of the activity used, independent of the concentration of the [ 125 I] iodine source used ( fig. 1 ). In addition, the tritium counts in the high energy part of the spectrum is l % or below. Therefore, the [ The determined counting efficiency of tritium in channel l was 67.8%.
Finally, graphs of radioactivity versus slice number were drawn for each sample and the cumulative height of the points in a singie peak attributable to receptor-bound hormone was measured above a diagrammatic baseline, which was introduced with the Computer from the minimum preceeding the peak to the minimum following the peak. This procedure gives similar results to those obtained using a baseline determined experimentally in the presence of a 200-fold molar excess of unlabelled hormone (18) . The amount of hormone whithin this peak was calculated and the result fmally expressed in fmol/mg supernatant protein. 
Results

Resolution of oestrogen receptor and progesterone receptor molecules
Both receptors are clearly separated from unbound hormone and unspecifically bound hormone, determined in the presence of a 200-fold molar excess of unlabelled hormone (18) . Furthermore, after isoelectric focussing and counting, both receptor peaks are clearly resolved in a single assay, irrespectively of the combinations of honnones used. In figure 2 The broad shape of the oestrogen receptor peak is not due to ineffective resolution of receptor molecules, but due to the omission of the limited trypsination procedure for the oestrogen receptor, to avoid digestion of progesterone receptor molecules (18).
Assays with cytosols
As a first Step and s a prerequisite for the section assay, we checked the double label assay in tumour cytosols of human mammary carcinomas. We compared the receptor tevels obtained by this assay with receptor levels determined in the single label assay with the same cytosol. As shown in figure 3 In summary, the values determined with the iodine label, which are determined directly, correlate better than those measured with the tritiated hormone, which in part is calculated indirectly by a mathematical transformation of data of the lower part of the beta-energy spectrum. The exception is the determination of [ 
Discussion
We have established the double isotope assay for the determination of steroid hormone receptors in extracts from cryostat sections. As a first Step, we adapted double isotope methods for Simultaneous receptor determination in cytosols (19 -22) to a cytosolic assay with isoelectric focussing for receptor quantitation. The results were comparable to those described in the literature (19) (20) (21) (22) . In a second Step, this method was used in the analysis of the receptor content in supernatants from frozen sections. During both Steps the dual label assay was checked against the respective single label assay performed in parallel. 
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Frac-tion no.
•1000 · § The advantages and disadvantages of the assay System described here can be listed s follows. 2. The amount of tissue (18) again has been further reduced by one half. Therefore, the assay can be performed with a quantity of tissue similar to that used in immunocytochemieal procedures. sulting peak pattern of oestrogen receptor and progesterone receptor serve s an additional quality control of the assay, and s described recently (18) receptor concentrations measured by isoelectric focussing are always higher than with the Standard dextrancoated charcol (DCC) assay.
However, one disadvantage cannot be concealed. The Separation step by isoelectric focussing makes this assay more time consuming than other assays. However, this procedure is necessary to concentrate receptor molecules in the rather dilute extracts of sections.
In conclusion, with respect to the amount of tissue needed, the described assay System is fc a biochemical alternative to immunocytochemical procedures, and it provides concentrations of receptors s the final result. We feel that the method is especially useful 1. when small specimens of mammary carcinomas have to be analysed biochemically for receptor content, 2. for research projects that simultaneously seek to determine receptor quantities and receptor localization. The assay is equally well applicable to cells grown in culture, and is an important tool if the receptor content has to be determined in a small number of cells.
